PMI Says Turkish Manufacturing Activity Contracts in August

FILE PHOTO-Alkan shoe sole manufacturer workers work in the factory at Antakya Organize Sanayi Bolgesi industrial complex in Belen, Hatay province, March 7, 2023. REUTERS/Susana Vera Purchase Licensing Rights
FILE PHOTO-Alkan shoe sole manufacturer workers work in the factory at Antakya Organize Sanayi Bolgesi industrial complex in Belen, Hatay province, March 7, 2023. REUTERS/Susana Vera Purchase Licensing Rights
TT

PMI Says Turkish Manufacturing Activity Contracts in August

FILE PHOTO-Alkan shoe sole manufacturer workers work in the factory at Antakya Organize Sanayi Bolgesi industrial complex in Belen, Hatay province, March 7, 2023. REUTERS/Susana Vera Purchase Licensing Rights
FILE PHOTO-Alkan shoe sole manufacturer workers work in the factory at Antakya Organize Sanayi Bolgesi industrial complex in Belen, Hatay province, March 7, 2023. REUTERS/Susana Vera Purchase Licensing Rights

Turkish factory activity contracted for the fifth month in a row in August as a slowdown in demand caused firms to scale back output, employment and purchasing activity.

The Purchasing Managers' Index (PMI) for Turkish manufacturing ticked up to 47.8 from 47.2 in July, according to a survey by the Istanbul Chamber of Industry and S&P Global, still standing below the 50-point level that marks growth in activity, Reuters reported.

Although new export orders returned to growth for the first time in more than a year, challenging market conditions led to a further softening of total new orders, the survey showed. Some firms reported that the slowdown in demand led them to reduce workforce numbers.

Input costs continued to rise with currency weakness being the main factor behind higher prices, according to the survey, and manufacturers in turn raised their output prices in August.

Firms were reluctant to hold inventories due to a slowdown in new orders, reducing their holdings of both purchases and finished goods, the survey showed.

"The subdued overall demand picture led to further scaling back of production, employment and purchasing," Andrew Harker, economics director at S&P Global Market Intelligence, said.

"Hopefully, the nascent recovery in exports seen in August will solidify in the months ahead and spread more widely to help the sector move into recovery mode."



Saudi Arabia Pushes to Boost Pharma Industry, Achieve Self-Sufficiency

A factory in al-Dammam produces various medical supplies, including face masks. (SPA)
A factory in al-Dammam produces various medical supplies, including face masks. (SPA)
TT

Saudi Arabia Pushes to Boost Pharma Industry, Achieve Self-Sufficiency

A factory in al-Dammam produces various medical supplies, including face masks. (SPA)
A factory in al-Dammam produces various medical supplies, including face masks. (SPA)

Saudi Arabia is working to boost its pharmaceutical and medical equipment industries by localizing production, increasing their GDP contribution, and reducing dependence on imports to achieve health security and self-sufficiency.

Currently, there are 206 facilities in these sectors, with investments totaling SAR 10 billion ($2.66 billion).

Saudi Industry Minister Bandar Alkhorayef recently discussed localizing vaccine and drug production with Brazilian counterparts, as this sector is a key focus of the National Industrial Strategy.

The goal is to strengthen the Kingdom’s independence in meeting medical needs and to develop the Kingdom into a major hub for this growing industry.

Fitch Solutions reported that Saudi Arabia’s pharmaceutical market was worth $11.72 billion (SAR 44 billion) in 2022 and is projected to reach $15.09 billion (SAR 56.6 billion) by 2027, growing at an annual rate of 5.2%.

To improve healthcare and provide services to all citizens, the Kingdom has allocated SAR 214 billion ($57 billion) in its 2024 budget for health and social development, in line with the Sustainable Development Goal of ensuring healthy lives for all.

As part of the National Industrial Strategy and Vision 2030, Saudi Arabia has localized the production of key medical products, including ventilators for intensive care units and blood glucose monitors and test strips.

Experts told Asharq Al-Awsat that localizing pharmaceutical and medical device production in Saudi Arabia will create high-paying jobs, ensure steady supplies, reduce import reliance, attract investment, and boost the Kingdom’s health security and self-sufficiency.

Speaking to Asharq Al-Awsat, Osama Al-Zamil, former Deputy Minister of Industry and Mineral Resources, emphasized the global economic impact of the pharmaceutical industry, which ranks second worldwide in sales.

He noted that Saudi Arabia is the largest pharmaceutical market in the Middle East and North Africa, valued at SAR 28 billion ($7.46 billion) in 2020, with projections to reach SAR 44.1 billion ($11.76 billion) by 2030.

Al-Zamil also highlighted the strong growth potential for the pharmaceutical and medical device sectors in the Kingdom.